Skip to main content
SpringerLink
Log in

Is ICRF-187 [(+)-1,2-Bis(3,5-dioxopiperazinyl-1-yl)propane] Unusually Reactive for an Imide?

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The hydrolysis of ICRF-187 and two model compounds, 4-methylpiperazine-2,6-dione (4-MP) and 3-methylglutarimide (3-MG), was investigated over the neutral to alkaline pH range at 25°C and an ionic strength of 0.5 (sodium chloride). The purpose of the study was to correlate the influence of molecular changes to the reactivity of these imides. Additionally, an improved chromatographic resolution of all the components of the degradation and NMR confirmation of the identity of the degradation products are presented. Based on the study of 4-MP, which is essentially half of an ICRF-187 molecule, and 3-MG, which has a carbon in place of the piperazine nitrogen, several conclusions can be drawn with regard to the stability of ICRF-187. The tertiary piperazine nitrogen/s of 4-MP and ICRF-187 contributed to the base-catalyzed hydrolysis of these compounds above pH 7 and caused a significant decrease in the pK a values of the imide moiety of ICRF-187 and 4-MP compared with 3-MG. One 2,6-piperazinedione ring of ICRF-187 was shown to affect only minimally the rate of hydrolysis of the second ring. ICRF-187 hydrolyzes by parallel consecutive pathways forming two monoacids with one ring opened and, subsequently, the diacid with both rings hy-drolyzed._________________________________

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. A. J. Repta, M. J. Baltezor, and P. C. Bansal. Utilization of an enantiomer as a solution to a pharmaceutical problem: Application to solubilization of 1,2-di-(4-piperazine-2,6-dione)propane. J. Pharm. Sci. 65:238–242 (1976).

    Google Scholar 

  2. K. Hellman and E. O. Field. Effect of ICRF 159 on the mammalian cell cycle. Significance for its use in cancer chemotherapy. J. Natl. Cancer Inst. 44:539–543 (1970).

    Google Scholar 

  3. R. J. Belt. Prevention of adriamycin-induced cardiotoxicity by ICRF-187 (NSC-169780). Proc. Am. Soc. Clin. Oncol. 3:Abstr. C-105 (1984).

  4. E. H. Herman. Influence of vitamin E and ICRF-187 on chronic cardiotoxicity in miniature swine. Lab. Invest. 49:69–77 (1983).

    Google Scholar 

  5. J. L. Speyer, M. D. Green, E. Kramer, M. Rey, J. Sanger, C. Waerd, N. Dubin, V. Ferrans, P. Stecy, A. Zeleniuch-Jacquotte, J. Wernz, F. Feir, W. Slater, R. Blum, and F. Muggia. Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer. N. Engl. J. Med. E. 319:745–752 (1988).

    Google Scholar 

  6. B. B. Hasinoff. The hydrolysis of the doxorubicin cardioprotective agent ICRF-187 ((+)-Bis(3,5-dioxopiperazinyl-l-yl) propone). Drug Metab. Disp. 18:344–349 (1990).

    Google Scholar 

  7. M. J. Baltezor. Preparation and Evaluation of Bis-(3-carboxy-4-hydroxy-1-naphthyl) Alkanones as Novel Complexing Agents. Complexation with some Quaternary Polycyclic Aromatic Compounds, Ph.D. dissertation, University of Kansas, Lawrence, 1976.

  8. A. Simonelli. A Report to the National Cancer Institute (Contract PH-43-68-1284), University of Michigan, Nov. 1971.

  9. M. N. Kahn and A. A. Khan. Kinetics and mechanism of hydrolysis of succinimide under highly alkaline medium. J. Org. Chem. 40:1793–1794 (1975).

    Google Scholar 

  10. J. T. Edward and K. A. Terry. The hydrolysis of amides and related compounds. IV. Diacetylamine and succinimide in aqueous alkali. J. Chem. Soc. 3527–3530 (1957).

  11. P. Nuhn and P. Woitkowitz. Alkalikatalysierte hydrolyse einiger succinimide. Pharmazie 33:202–205 (1978).

    Google Scholar 

  12. G. J. Yakatan and T. Fan. Kinetics of hydrolysis of succinimides. Drug Dev. Ind. Pharm. 3:315–338 (1977).

    Google Scholar 

  13. J. Tirouflet and E. Le Trouit. Cinetique de 1'Hydrolyse des Phtalimides en Milieu Tampon (Dosage Polarographique). C.R. Acad. Sci. 241:1053–1055 (1955).

    Google Scholar 

  14. J. W. Wesolowski, S. M. Blaug, T. F. Chin, and J. L. Lach. Kinetics of degradation of glutethimide. J. Pharm. Sci. 57:811–815 (1968).

    Google Scholar 

  15. T. Yamana and Y. Mizukami. Studies on the stability of drugs. IV. On the decomposition of glutethimide in alkaline solution. Yakagaku Zasshi 81:1383–1386 (1961).

    Google Scholar 

  16. B. H. Chase and A. M. Downes. The synthesis of 14C-labelled l-diethylcarbamyl-4-methylpiperazine (“Hetrazan”). J. Chem. Soc. 3874–3877 (1953).

  17. K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno. A pharmacokinetic analysis program (MULTI) for microcomputers. J. Pharm. Dyn. 4:879–885 (1981).

    Google Scholar 

  18. A. Albert and E. P. Serjeant. Determination of Ionization Constants, 3rd ed., Chapman and Hall, New York, 1984, pp. 70–101, 14–39, 130–134.

    Google Scholar 

  19. E. C. Kornfeld, R. G. Jones, and T. V. Park. The structure and chemistry of actidone, an antibiotic from Streptomyces griseus. J. Am. Chem. Soc. 71:150–159 (1949).

    Google Scholar 

  20. D. D. Perrin, B. Dempsey, and E. P. Serjeant. pKa Prediction for Organic Acids and Bases, Chapman and Hall, New York, 1981, pp. 13–15, 16.

    Google Scholar 

  21. H. F. Walton and A. A. Schilt. The ionization constant and rate of hydrolysis of succinimide. J. Am. Chem. Soc. 74:4995–4996 (1952).

    Google Scholar 

  22. H. V. Euler and A. Olander. Uber die Hydrolytische Spaltung des Succinimids. Z. Phys. Chem. 137:393–398 (1931).

    Google Scholar 

  23. M. Bergon and J. P. Calmon. Kinetics and mechanism of hydantoic ring opening. The alkaline hydrolysis of 3-arylimidazolidine-2,4-diones to 5-arylhydantoic acids. J. Chem. Soc. Perkin II 493–497 (1978).

  24. K. M. Dawson. Studies on the stability and cellular distribution of dioxopiperazines in cultured BHK-21S cells. Biochem. Pharmacol. 24:2249–2253 (1975).

    Google Scholar 

  25. T. G. Burke, T. D. Lee, J. van Balgooy, and J. H. Doroshaw. Characterization of the aqueous decomposition products of (+)l,2-bis(3,5-dioxopiperazinyl-1-yl)-propane (ICRF-187) by liquid chromatographic and mass spectral analysis. J. Pharm. Sci. 80:338–340 (1991).

    Google Scholar 

  26. C. Dorlet. Etude de l'Hydrolyse Alcaline de l'α-ethyl-α-phenyl Glutarimide. J. Pharm. Belg. 24:509–520 (1969).

    Google Scholar 

  27. B. R. Vishnuvajjala and J. C. Cradock. Tricyclo[4.2.2.02,5]dec-9-ene-3,4,7,8-tetracarboxylic acid dimide: Formulation and stability studies. J. Pharm. Sci. 75:301–303 (1986).

    Google Scholar 

  28. W. Sadee, J. Staroscik, C. Finn, and J. Cohen. Determination of (±)-1,2-bis(3,5-dioxopiperazinyl)propane plasma levels in rats, rabbits, and humans by GLC and mass fragmentography. J. Pharm. Sci. 64:998–1001 (1975).

    Google Scholar 

Download references

Author information

Author notes

  1. Jay M. Sisco

    Present address: Glaxo Inc., Research Triangle Park, North Carolina

Authors and Affiliations

  1. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas, 66045

    Jay M. Sisco & Valentino J. Stella

Authors
  1. Jay M. Sisco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Valentino J. Stella
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sisco, J.M., Stella, V.J. Is ICRF-187 [(+)-1,2-Bis(3,5-dioxopiperazinyl-1-yl)propane] Unusually Reactive for an Imide?. Pharm Res 9, 1076–1082 (1992). https://doi.org/10.1023/A:1015818931062

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015818931062

Search

Navigation